Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CR.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.8.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EC.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.87 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XNENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.111 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used